From f4dfe8c899c69e79f90e48939bee62a32939f0d3 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:32:54 +0200 Subject: [PATCH 01/18] New translations introduction.md (Romanian) --- docs/CROWDIN/ro/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/ro/Getting-Started/Introduction.md b/docs/CROWDIN/ro/Getting-Started/Introduction.md index 2ac14c899374..e15158dacbd9 100644 --- a/docs/CROWDIN/ro/Getting-Started/Introduction.md +++ b/docs/CROWDIN/ro/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From 3d335046561f01db8fa81632f0849a1c34ed4015 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:32:55 +0200 Subject: [PATCH 02/18] New translations introduction.md (French) --- docs/CROWDIN/fr/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/fr/Getting-Started/Introduction.md b/docs/CROWDIN/fr/Getting-Started/Introduction.md index 9f576d216589..cd3f4b9c707e 100644 --- a/docs/CROWDIN/fr/Getting-Started/Introduction.md +++ b/docs/CROWDIN/fr/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ Aucun système d'administration d'insuline automatique n'est parfait. Les systè **AAPS** est totalement transparent, logique et prévisible, ce qui peut faciliter la compréhension lorsque qu'un paramètre est incorrect et permet de l'ajuster en conséquence. Vous pouvez voir exactement ce que fait le système, pourquoi il le fait, et définissez ses limites opérationnelles, ce qui met le contrôle (et la responsabilité) entre vos mains. L'utilisateur peut gagner en assurance et bénéficier d'un sommeil plus tranquille. #### 11) **Accès à des fonctionnalités avancées via les modes de développement (dev), y compris la boucle fermée complète** -Cette documentation **AAPS** se concentre sur la branche principale **“master”** de **AAPS**. Cependant, la recherche et le développement n'arrêtent jamais. Les utilisateurs plus expérimentés peuvent souhaiter explorer les fonctionnalités expérimentales dans la branche de **développement**. Cela inclut l'intégration du Dexcom G7 et l'ajustement automatique de l'injection d'insuline en fonction des changements de sensibilité à court terme (DYNISF). Les innovations en matière de développement se concentrent sur des stratégies de boucle fermée totale (sans avoir à saisir de bolus pour les repas _etc._), et essayent de manière générale de rendre la vie avec le diabète de type 1 aussi facile que possible. +Cette documentation **AAPS** se concentre sur la branche principale **“master”** de **AAPS**. Cependant, la recherche et le développement n'arrêtent jamais. Les utilisateurs plus expérimentés peuvent souhaiter explorer les fonctionnalités expérimentales dans la branche de **développement**. Les innovations en matière de développement se concentrent sur des stratégies de boucle fermée totale (sans avoir à saisir de bolus pour les repas _etc._), et essayent de manière générale de rendre la vie avec le diabète de type 1 aussi facile que possible. #### 12) **Possibilité de contribuer vous-même à l'ajout de nouvelles fonctionnalités** Le diabète de type 1 peut être très frustrant et isole les personnes. Avoir le contrôle de votre propre système technologique pour votr diabète, avec la possibilité de contribuer à votre tour dès que vous faites des progrès en aidant les autres dans leur cheminement peut être vraiment gratifiant. Vous pouvez vous former, mettre au jour des obstacles, faire des recherches et même contribuer à de nouveaux développements et à la documentation. Vous trouverez d'autres personnes dans la communauté avec qui partager la même envie de progresser, avec qui réfléchir et travailler. C'est l'essence même du mouvement #WeAreNotWaiting. From e40be89b424195679beadb57178aa9d42349e4e9 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:32:57 +0200 Subject: [PATCH 03/18] New translations introduction.md (Spanish) --- docs/CROWDIN/es/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/es/Getting-Started/Introduction.md b/docs/CROWDIN/es/Getting-Started/Introduction.md index 36b2dc1f8972..24719c343290 100644 --- a/docs/CROWDIN/es/Getting-Started/Introduction.md +++ b/docs/CROWDIN/es/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Los sistemas comerciales y de c **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. Puedes ver exactamente lo que el sistema está haciendo, por qué lo está haciendo y establecer sus límites operativos, lo que coloca el control (y la responsabilidad) en tus manos. Esto puede brindar al usuario confianza y un sueño más tranquilo. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Tener el control sobre tu propia tecnología para la diabetes, con la posibilidad de "retribuir" tan pronto como haces progresos al ayudar a otros en su camino, puede ser realmente gratificante. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. Esta es la esencia de #WeAreNotWaiting. From 64532b8ad5677610c4d19a6ea6dad80c604cef55 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:32:59 +0200 Subject: [PATCH 04/18] New translations introduction.md (Czech) --- docs/CROWDIN/cs/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/cs/Getting-Started/Introduction.md b/docs/CROWDIN/cs/Getting-Started/Introduction.md index 8b2973473c62..baf39dd874e7 100644 --- a/docs/CROWDIN/cs/Getting-Started/Introduction.md +++ b/docs/CROWDIN/cs/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ S **AAPS** je snadné sledovat věci jako: množství inzulínu v pumpě, stář **AAPS** je zcela transparentní, logický a předvídatelný algoritmus, což může usnadnit rozpoznání špatného nastavení a odpovídajícím způsobem jej upravit. Přesně vidíte, co systém dělá a proč to dělá. Natavením provozních limitů bude kontrola (a odpovědnost) ve vašich rukou. To může uživateli poskytnout důvěru a klidný spánek. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -Tato dokumentace **AAPS** se zaměřuje na hlavní - nejstandardnější - **„master“** větev **AAPS**. Výzkum a vývoj však stále pokračuje. Zkušenější uživatelé mohou zkoušet objevovat experimentální funkce v **vývojové větvi**. To zahrnuje integraci senzoru Dexcom G7 a automatickou úpravu dodávky inzulinu podle krátkodobých změn citlivosti (DYNISF). Inovace v oblasti rozvoje se zaměřují na strategie pro úplnou uzavřenou smyčku (zcela bez bolusování k jídlu _apod._) a obecně se snaží o co nejpohodlnější život s diabetem 1. typu. +Tato dokumentace **AAPS** se zaměřuje na hlavní - nejstandardnější - **„master“** větev **AAPS**. Výzkum a vývoj však stále pokračuje. Zkušenější uživatelé mohou zkoušet objevovat experimentální funkce v **vývojové větvi**. Inovace v oblasti rozvoje se zaměřují na strategie pro úplnou uzavřenou smyčku (zcela bez bolusování k jídlu _apod._) a obecně se snaží o co nejpohodlnější život s diabetem 1. typu. #### 12) **Ability to contribute yourself to further improvements** Diabetes typu 1 může být velmi frustrující a můžete mít pocit, že jste na to sami. Získání kontroly nad vlastní technikou pro zvládání diabetu s možností "splacení" formou pomoci ostatním, jak se postupně zlepšujete, může být velmi obohacující. Můžete se sami vzdělávat a rozvíjet, objevovat a vyhledávat překážky a dokonce přispívat k novému vývoji a dokumentaci. Cestou potkáte další lidi se stejným cílem, se kterými můžete sdílet nápady a pracovat na nich společně. Tohle je podstata #WeAreNotWaiting. From f4abaf1eff45868d90e5e93225f64d99f7597689 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:00 +0200 Subject: [PATCH 05/18] New translations introduction.md (German) --- docs/CROWDIN/de/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/de/Getting-Started/Introduction.md b/docs/CROWDIN/de/Getting-Started/Introduction.md index 150da9cbce2d..156e1fefb736 100644 --- a/docs/CROWDIN/de/Getting-Started/Introduction.md +++ b/docs/CROWDIN/de/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ Kein automatisiertes Insulinsystem ist perfekt. Kommerzielle und Open-Source-Sys **AAPS** ist völlig transparent, logisch und berechenbar was es einfacher machen kann zu wissen, wann eine Einstellung falsch ist, und sie entsprechend anzupassen. Du kannst zu jeder Zeit genau sehen, was das System tut, warum es das tut und die Kontrolle wieder in Deine Hand nehmen, indem Du entsprechende Grenzen setzt. Dies schafft Vertrauen und Dir einen erholsameren Schlaf. #### 11) **Zugriff auf erweiterte Funktionen durch Entwicklungsmodi (dev) einschließlich vollständigem Closed Loop** -Diese **AAPS** Dokumentation konzentriert sich auf die Hauptentwicklung im **“master”**-Branch [in Git] von **AAPS**. Forschung und Entwicklung laufen jedoch ständig. Erfahrene Benutzer können die experimentellen Funktionen im **"development"**-Branch erkunden. Dazu gehört die Integration von Dexcom G7 und die automatische Anpassung der Insulinlieferung an kurzfristige Sensibilitätsänderungen (DYNISF). Die Neuentwicklungen konzentrieren sich auf Strategien zum vollständigen Closed Loop (ohne Bolus für Mahlzeiten _usw._) und versuchen ganz allgemein, das Leben mit Typ-1-Diabetes so angenehm wie möglich zu machen. +Diese **AAPS** Dokumentation konzentriert sich auf die Hauptentwicklung im **“master”**-Branch [in Git] von **AAPS**. Forschung und Entwicklung laufen jedoch ständig. Erfahrene Benutzer können die experimentellen Funktionen im **"development"**-Branch erkunden. Die Neuentwicklungen konzentrieren sich auf Strategien zum vollständigen Closed Loop (ohne Bolus für Mahlzeiten _usw._) und versuchen ganz allgemein, das Leben mit Typ-1-Diabetes so angenehm wie möglich zu machen. #### 12) **Möglichkeit, sich an weiteren Verbesserungen zu beteiligen** Diabetes Typ 1 kann sehr frustrierend sein und dazu führen, dass Du Dich alleingelassen fühlst. Seine Diabetes-Technolgie selber unter Kontrolle zu haben und etwas an die Community zurückzugeben ("pay it forward") indem Du andere bei deren Reise unterstützst, kann ein gutes und befriedigendes Gefühl geben. Du kannst Dich selbst weiterbilden, Hindernisse erkennen und auch Deine Beiträge zur Weiterentwicklung und/oder zur Dokumentation leisten. In der Community gibt es andere, die das gleiche Ziel haben und mit denen Du Ideen austauschen und zusammenarbeiten kannst. Dies ist die Grundidee und der Geist von #WeAreNotWaiting. From 055d4f60390651f934a18ecd001f26149e037f66 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:02 +0200 Subject: [PATCH 06/18] New translations introduction.md (Greek) --- docs/CROWDIN/el/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/el/Getting-Started/Introduction.md b/docs/CROWDIN/el/Getting-Started/Introduction.md index 283f7aeb8be4..c312f681c41f 100644 --- a/docs/CROWDIN/el/Getting-Started/Introduction.md +++ b/docs/CROWDIN/el/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From a84c3f7f4be1348b0af0b9c9974b4990919c308f Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:04 +0200 Subject: [PATCH 07/18] New translations introduction.md (Hebrew) --- docs/CROWDIN/he/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/he/Getting-Started/Introduction.md b/docs/CROWDIN/he/Getting-Started/Introduction.md index 80cf009b9353..e7995d2d3ebe 100644 --- a/docs/CROWDIN/he/Getting-Started/Introduction.md +++ b/docs/CROWDIN/he/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From f82f5189385e5df6251004cd567eac86c5d79e5c Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:06 +0200 Subject: [PATCH 08/18] New translations introduction.md (Korean) --- docs/CROWDIN/ko/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/ko/Getting-Started/Introduction.md b/docs/CROWDIN/ko/Getting-Started/Introduction.md index 86b286773d57..937bb7a73d35 100644 --- a/docs/CROWDIN/ko/Getting-Started/Introduction.md +++ b/docs/CROWDIN/ko/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From 6f951484cd765b71485e4a2ec96c00d9db11d9f0 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:08 +0200 Subject: [PATCH 09/18] New translations introduction.md (Lithuanian) --- docs/CROWDIN/lt/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/lt/Getting-Started/Introduction.md b/docs/CROWDIN/lt/Getting-Started/Introduction.md index 3021104f03d3..fcfd25c5e5dc 100644 --- a/docs/CROWDIN/lt/Getting-Started/Introduction.md +++ b/docs/CROWDIN/lt/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From 22747a509e8b458d78e5230b52ae02cef8ff3b5d Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:09 +0200 Subject: [PATCH 10/18] New translations introduction.md (Dutch) --- docs/CROWDIN/nl/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/nl/Getting-Started/Introduction.md b/docs/CROWDIN/nl/Getting-Started/Introduction.md index 22c23552225b..1c59cbe015dd 100644 --- a/docs/CROWDIN/nl/Getting-Started/Introduction.md +++ b/docs/CROWDIN/nl/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From 1e6b5d1df23fbde803b8d43b58904c5577e3460b Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:11 +0200 Subject: [PATCH 11/18] New translations introduction.md (Polish) --- docs/CROWDIN/pl/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/pl/Getting-Started/Introduction.md b/docs/CROWDIN/pl/Getting-Started/Introduction.md index 6069b7cd241f..ecc1d3fd3b27 100644 --- a/docs/CROWDIN/pl/Getting-Started/Introduction.md +++ b/docs/CROWDIN/pl/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From 8695d7c114e11dcfc6886a2ed7fa8179bb95db9f Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:13 +0200 Subject: [PATCH 12/18] New translations introduction.md (Portuguese) --- docs/CROWDIN/pt/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/pt/Getting-Started/Introduction.md b/docs/CROWDIN/pt/Getting-Started/Introduction.md index 6069b7cd241f..ecc1d3fd3b27 100644 --- a/docs/CROWDIN/pt/Getting-Started/Introduction.md +++ b/docs/CROWDIN/pt/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From a18435e19d37199907812875a501496fc0da61e3 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:14 +0200 Subject: [PATCH 13/18] New translations introduction.md (Russian) --- docs/CROWDIN/ru/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/ru/Getting-Started/Introduction.md b/docs/CROWDIN/ru/Getting-Started/Introduction.md index fb7517343b82..2b35af24b427 100644 --- a/docs/CROWDIN/ru/Getting-Started/Introduction.md +++ b/docs/CROWDIN/ru/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ There are multiple possible monitoring channels (Sugarmate, Dexcom Follow, xDrip **AAPS** полностью прозрачен, логичен и предсказуемо,, что может облегчить выявление ошибочных настроек, и их коррекцию. Вы всегда точно видите, что делает система, почему она это делает, задаете свои ограничения, которые оставляют контроль (и ответственность) в ваших руках. А это, в свою очередь, обеспечивает уверенность и здоровый сон пользователя. #### 11) **Доступ к расширенным функциям через режимы разработки (dev), включая полный цикл** -Эта документация **AAPS** фокусируется на основной ветке **“master”** **AAPS**. Однако научные исследования и разработки продолжаются все время. Более опытные пользователи могут захотеть изучить экспериментальные функции ветки **разработчиков**. Сюда входит интеграция с Dexcom G7, автоматическую настройку введения инсулина в соответствии с краткосрочными изменениями чувствительности (DYNISF). Инновации в области развития сосредоточены на стратегиях полного замкнутого цикла (без подколок на еду _и т. д._), и, как правило, стремятся сделать качество жизни с диабетом 1 типа как можно выше. +Эта документация **AAPS** фокусируется на основной ветке **“master”** **AAPS**. Однако научные исследования и разработки продолжаются все время. Более опытные пользователи могут захотеть изучить экспериментальные функции ветки **разработчиков**. Инновации в области развития сосредоточены на стратегиях полного замкнутого цикла (без подколок на еду _и т. д._), и, как правило, стремятся сделать качество жизни с диабетом 1 типа как можно выше. #### 12) **Возможность вносить вклад в дальнейшие улучшения** Диабет 1 типа может создавать чувство незащищенности и одиночества. Контролируя собственные технологии преодоления диабета, имея возможность внести свой вклад в эти усилия, вы почувствуете удовлетворение от пользы, которую приносите другим. Вы можете получать новые знания, преодолевать трудности и вносить вклад в новые разработки и документацию. Идущие по этому пути будут обмениваться с вами идеями и совместно преодолевать трудности. Смысл движения #WeAreNotWaiting именно в этом. From 0af66e7a70235d82ea4d96b0d10016b4ea5c899b Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:16 +0200 Subject: [PATCH 14/18] New translations introduction.md (Slovak) --- docs/CROWDIN/sk/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/sk/Getting-Started/Introduction.md b/docs/CROWDIN/sk/Getting-Started/Introduction.md index 6069b7cd241f..ecc1d3fd3b27 100644 --- a/docs/CROWDIN/sk/Getting-Started/Introduction.md +++ b/docs/CROWDIN/sk/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From 1ef3326bac7ab9dc61b848d68b29e3479aeaf720 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:18 +0200 Subject: [PATCH 15/18] New translations introduction.md (Turkish) --- docs/CROWDIN/tr/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/tr/Getting-Started/Introduction.md b/docs/CROWDIN/tr/Getting-Started/Introduction.md index 8cc09965d18f..59a35ecfeb35 100644 --- a/docs/CROWDIN/tr/Getting-Started/Introduction.md +++ b/docs/CROWDIN/tr/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting. From cb6164982980a198b12122c53950dff0770350b9 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:19 +0200 Subject: [PATCH 16/18] New translations introduction.md (Chinese Simplified) --- docs/CROWDIN/zh_CN/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/zh_CN/Getting-Started/Introduction.md b/docs/CROWDIN/zh_CN/Getting-Started/Introduction.md index 259cf3c3c063..ec3e44acc3bc 100644 --- a/docs/CROWDIN/zh_CN/Getting-Started/Introduction.md +++ b/docs/CROWDIN/zh_CN/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ AAPS的“中枢”是您自己构建的 **应用程序**。 构建过程有详 **AAPS** 是完全透明、逻辑清晰且行为可预测的，这有助于及时发现配置错误并进行相应调整。 你可以精准地看到系统正在做什么，为什么这么做，然后给它设定操作限制，这能让你始终掌握系统的控制权（还有相应的责任）。 这样既能增强用户信心，也能睡个安稳觉。 #### 11) **通过开发（dev）模式获得高级功能（包括全闭环）** -本 **AAPS** 文档侧重于 **AAPS** 开发项目的** "主 （master）"**分支。 然而，研发工作一直在进行。 更有经验的用户可能希望探索**开发分支**中的实验功能。 这包括集成 Dexcom G7 ，以及根据短期敏感性变化自动调整胰岛素给药量（DYNISF）。 开发创新的重点是全闭环策略（不必输注餐前大剂量_等_），总体而言，就是要尽可能方便 1 型糖尿病患者的生活。 +本 **AAPS** 文档侧重于 **AAPS** 开发项目的** "主 （master）"**分支。 然而，研发工作一直在进行。 更有经验的用户可能希望探索**开发分支**中的实验功能。 开发创新的重点是全闭环策略（不必输注餐前大剂量_等_），总体而言，就是要尽可能方便 1 型糖尿病患者的生活。 #### 12) **为进一步改进做出自己的贡献** 1 型糖尿病会让人感到非常沮丧和孤独。 当掌控了自己的控糖装备以后，你就有了为其他糖友提供帮助的能力，在“把关怀与支持传递下去”的路途上，哪怕只有些许的效果你都会很有成就感。 你可以自学自教，发现问题并去寻找新的研究进展和文献资料，乃至为问题的解决贡献一份力量。 在社区中，还有其他人有着同样的追求，你可以与他们交流想法，一起合作。 这是#WeAreNotWaiting运动的精髓。 From 1af5b20a8bd9e62828170f2a7e6353ea588745d6 Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:21 +0200 Subject: [PATCH 17/18] New translations introduction.md (Chinese Traditional) --- docs/CROWDIN/zh_TW/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/zh_TW/Getting-Started/Introduction.md b/docs/CROWDIN/zh_TW/Getting-Started/Introduction.md index 1d90caec9bd4..5e3db23c8caa 100644 --- a/docs/CROWDIN/zh_TW/Getting-Started/Introduction.md +++ b/docs/CROWDIN/zh_TW/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ AAPS 的“核心”是一個你自己建置的**應用程式**。 這裡有詳 **AAPS** 完全透明、邏輯清晰且可預測，這可能會使你更容易知道何時設置出錯，並相應地進行調整。 你可以完全看到系統在做什麼、為什麼這樣做，以及設置其運作限制，這使得控制權（和責任）掌握在你手中。 這可以讓用戶感到更有信心，並能擁有更好的睡眠品質。 #### 11) **透過開發（dev）模式查看進階功能，包括全閉環** -這份**AAPS** 文件主要集中於**“master”**分支的主流版本。 然而，研究和開發始終在進行中。 更有經驗的用戶可能希望探索**開發**分支中的實驗性功能。 這包括Dexcom G7的整合，以及根據短期敏感度變化（DYNISF）自動調整胰島素輸送的功能。 開發創新主要集中於全閉環的策略（不必為用餐注射_其他_等胰島素），並一般地努力使1型糖尿病患者的生活變得更方便。 +這份**AAPS** 文件主要集中於**“master”**分支的主流版本。 然而，研究和開發始終在進行中。 更有經驗的用戶可能希望探索**開發**分支中的實驗性功能。 開發創新主要集中於全閉環的策略（不必為用餐注射_其他_等胰島素），並一般地努力使1型糖尿病患者的生活變得更方便。 #### 12) **能夠自行參與進一步的改善** 第1型糖尿病可能會讓人感到非常沮喪和孤立。 掌控自己的糖尿病技術，並且在取得進展後幫助他人，這可以帶來極大的成就感。 你可以自我學習，發現障礙，尋求解決方案，甚至為新的開發和文件貢獻力量。 社群中有與你有相同目標的人可以與你交換想法並合作。 這就是 #WeAreNotWaiting 的核心精神。 From d62ad580b774212aa640d416ab785762d3921c8c Mon Sep 17 00:00:00 2001 From: Milos Kozak Date: Wed, 25 Jun 2025 18:33:23 +0200 Subject: [PATCH 18/18] New translations introduction.md (Portuguese, Brazilian) --- docs/CROWDIN/pb/Getting-Started/Introduction.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/docs/CROWDIN/pb/Getting-Started/Introduction.md b/docs/CROWDIN/pb/Getting-Started/Introduction.md index 6069b7cd241f..ecc1d3fd3b27 100644 --- a/docs/CROWDIN/pb/Getting-Started/Introduction.md +++ b/docs/CROWDIN/pb/Getting-Started/Introduction.md @@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep. #### 11) **Access to advanced features through development (dev) modes including full closed loop** -This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. +This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible. #### 12) **Ability to contribute yourself to further improvements** Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting.